ArticleMediterranean journal of hematology and infectious diseases2012
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients.
Saveria Capria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.